There are 142 resources available
Invited Discussant of abstracts 40MO and 74MO
Presenter: Robert Coleman
Session: Mini Oral session
Resources:
Slides
Webcast
Introduction
Presenter: Isabelle Ray-Coquard
Session: Rare cancers
Resources:
Webcast
State-of-the-art management in carcinosarcoma: From the biology to treatment
Presenter: Ignacio Romero
Session: Rare cancers
Resources:
Slides
Webcast
Is immune therapy definitely required for all clear cell carcinoma?
Presenter: Alexandra Leary
Session: Rare cancers
Resources:
Slides
Webcast
Which drugs could be relevant for LGSC: The present and future
Presenter: Charlie Gourley
Session: Rare cancers
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Rare cancers
Resources:
Webcast
Welcome and introduction
Presenter: Ana Oaknin
Session: Seagen - Driving towards the future of r/m cervical cancer treatment: Take a front seat for interactive expert perspectives on emerging and potential future therapy options
Resources:
Webcast
What has changed and what's next in the 1L setting for r/m CC?
Presenter: Ana Oaknin
Session: Seagen - Driving towards the future of r/m cervical cancer treatment: Take a front seat for interactive expert perspectives on emerging and potential future therapy options
Resources:
Webcast
What's new and how can we improve 2L management of r/m CC?
Presenter: Isabelle Ray-Coquard
Session: Seagen - Driving towards the future of r/m cervical cancer treatment: Take a front seat for interactive expert perspectives on emerging and potential future therapy options
Resources:
Webcast
Key messages and close
Presenter: Ana Oaknin
Session: Seagen - Driving towards the future of r/m cervical cancer treatment: Take a front seat for interactive expert perspectives on emerging and potential future therapy options
Resources:
Webcast